From the authors

European Respiratory Journal

Volumn 43, Issue 4, 2014, Pages 1204-1205

  Bateman, Eric ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLYCOPYRRONIUM BROMIDE; GLYCOPYRRONIUM BROMIDE PLUS INDACATEROL; INDACATEROL; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; INDAN DERIVATIVE; QUINOLONE DERIVATIVE;

BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; LETTER; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; MONOTHERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; ANALOGS AND DERIVATIVES; FEMALE; MALE;

BRONCHODILATOR AGENTS; FEMALE; GLYCOPYRROLATE; HUMANS; INDANS; MALE; QUINOLONES;

EID: 84897398892     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00156313     Document Type: Letter

References (7)

1. Bateman ED, Ferguson GT, Barnes N, et al Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J 2013; 42: 1484-1494.
2. Donohue JF. Minimal clinically important differences in COPD lung function. COPD 2005; 2: 111-124.
3. Witek TJ J.r., Mahler DA Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003; 21: 267-272.
4. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404.
5. European Medicines Agency. Guidelines on clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD). London, European Medicines Agency, 2012.
6. Wang J, Jin D, Zuo P., et al Comparison of tiotropium plus formoterol to tiotropium alone in stable chronic obstructive pulmonary disease: a meta-analysis. Respirology 2011; 16: 350-358.
7. Mahler DA, D'Urzo A, Peckitt C, et al Combining once-daily bronchodilators in COPD: indacaterol plus tiotropium versus tiotropium alone. Am J Respir Crit Care Med 2011; 183: 1591.